Prevention of venous thromboembolism in gynecologic oncology surgery

Emma L. Barber*, Daniel L. Clarke-Pearson

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

42 Scopus citations


Gynecologic oncology patients are at a high-risk of postoperative venous thromboembolism and these events are a source of major morbidity and mortality. Given the availability of prophylaxis regimens, a structured comprehensive plan for prophylaxis is necessary to care for this population. There are many prophylaxis strategies and pharmacologic agents available to the practicing gynecologic oncologist. Current venous thromboembolism prophylaxis strategies include mechanical prophylaxis, preoperative pharmacologic prophylaxis, postoperative pharmacologic prophylaxis and extended duration pharmacologic prophylaxis that the patient continues at home after hospital discharge. In this review, we will summarize the available pharmacologic prophylaxis agents and discuss currently used prophylaxis strategies. When available, evidence from the gynecologic oncology patient population will be highlighted.

Original languageEnglish (US)
Pages (from-to)420-427
Number of pages8
JournalGynecologic oncology
Issue number2
StatePublished - Feb 1 2017


  • Deep vein thrombosis
  • Gynecologic surgery
  • Pharmacologic prophylaxis
  • Pulmonary embolism
  • Venous thromboembolism

ASJC Scopus subject areas

  • Obstetrics and Gynecology
  • Oncology


Dive into the research topics of 'Prevention of venous thromboembolism in gynecologic oncology surgery'. Together they form a unique fingerprint.

Cite this